CeruleanFusions
commented on
$Nuburu(BURU.US$ I bought in at 17.. it's now at 9 with a loss of 2,500.. but still have 2,700 invested... what should I do??? sell hold buymore??
8
CeruleanFusions
commented on
$MicroAlgo(MLGO.US$ still in at 11.3
1
11
CeruleanFusions
reacted to
$Virios Therapeutics(VIRI.US$ Trying to get into that gap‼️⏳💥
1
CeruleanFusions
commented on
$Virios Therapeutics(VIRI.US$ Added .185 looking for .35 on swing trade‼️
1
3
CeruleanFusions
voted
$GameStop(GME.US$, is defying gravity again, surging by 110% on Monday without a clear catalyst—a move that briefly froze trading.
Options activity is at the heart of the frenzy, with volumes skyrocketing by 500%.
GME's resurgence will spark déjà vu for those versed in the 2021 retail vs. short-seller drama.
This latest price surge?
It's all thanks to a cryptic post from Keith Gill, GameStop's storied protagonist who once inspired ...
GME's resurgence will spark déjà vu for those versed in the 2021 retail vs. short-seller drama.
This latest price surge?
It's all thanks to a cryptic post from Keith Gill, GameStop's storied protagonist who once inspired ...
![Striking gold in options trading: what's behind GME's frenzy?](https://sgsnsimg.moomoo.com/sns_client_feed/103132832/20240515/1715763906844-6bb173e495.png/thumb?area=101&is_public=true)
![Striking gold in options trading: what's behind GME's frenzy?](https://sgsnsimg.moomoo.com/sns_client_feed/103132832/20240515/1715763947246-719a94f922.png/thumb?area=101&is_public=true)
![Striking gold in options trading: what's behind GME's frenzy?](https://sgsnsimg.moomoo.com/sns_client_feed/103132832/20240515/1715764742265-ae44f293d6.webp/thumb?area=101&is_public=true)
+5
38
2
CeruleanFusions
commented on
$GameStop(GME.US$ every single time i join the party it tanks.
8
5
CeruleanFusions
reacted to
$Virios Therapeutics(VIRI.US$ Virios Therapeutics Announces Publication Of International Patent For IMC-2 Covering Antiviral Treatment Of Long-COVID
Benzinga· 1 min ago
Benzinga· 1 min ago
2
CeruleanFusions
reacted to
$Virios Therapeutics(VIRI.US$ Virios Therapeutics (NASDAQ:VIRI) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.09) by 33.33 percent.
1